- Is Amyloidosis Research Consortium a tax-exempt 501(c)(3)?
- Yes. Amyloidosis Research Consortium is recognised by the IRS as a 501(c)(3) organisation (EIN 47-2589708). The IRS recognised Amyloidosis Research Consortium as tax-exempt in August 2015.
- What is Amyloidosis Research Consortium's EIN?
- Amyloidosis Research Consortium's Employer Identification Number (EIN) is 47-2589708. The EIN was assigned by the IRS in August 2015. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Amyloidosis Research Consortium do?
- Accelerating the development of advanced diagnostic tools and effective treatments for systemic Amyloidosis through collaboration and innovation.
- Where is Amyloidosis Research Consortium located?
- Amyloidosis Research Consortium is located at 320 Nevada Street Suite 210, Newton, MA, 02460.
- When was Amyloidosis Research Consortium founded or recognised by the IRS?
- Amyloidosis Research Consortium was recognised by the IRS as a tax-exempt organisation in August 2015. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Amyloidosis Research Consortium's annual revenue?
- On its most recent Form 990 (fiscal year 2025), Amyloidosis Research Consortium reported $3.8M in total revenue and $3.8M in total expenses.
- Has Amyloidosis Research Consortium been auto-revoked by the IRS?
- No. Amyloidosis Research Consortium (EIN 47-2589708) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Amyloidosis Research Consortium listed in IRS Publication 78?
- Yes. Amyloidosis Research Consortium is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
